2. Search Result
Search Result
Results for "

staphylococci

" in MedChemExpress (MCE) Product Catalog:

60

Inhibitors & Agonists

2

Peptides

9

Natural
Products

6

Isotope-Labeled Compounds

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-B0925
    Oxacillin sodium salt
    Maximum Cited Publications
    12 Publications Verification

    		 Bacterial Antibiotic Infection
    Oxacillin sodium salt is an orally active synthetic penicillin with good bactericidal activity against staphylococci and other gram-positive pathogens .
    Oxacillin sodium salt
  • HY-100997
    Chloroorienticin A

    A82846B; LY 264826; PA 45052A

    		 Antibiotic Infection
    Chloroorienticin A (A82846B) is a glycopeptide antibiotic. Chloroorienticin A exhibits excellent activity against staphylococci and streptococci .
    Chloroorienticin A
  • HY-129435
    Altromycin E

    		Antibiotic Bacterial Infection Cancer
    Altromycin E is an antibiotic, that exhibits antibacterial against Streptococci and Staphylococci with MIC of 0.2-3.12 μg/mL. Altromycin E can be used in anti-tumor research .
    Altromycin E
  • HY-148209
    Balhimycin

    		Antibiotic Bacterial Infection
    Balhimycin is a glycopeptide antibiotic, found from the fermentation broth of a Amycolatopsis sp. Balhimycin shows anti-bacterial activity against staphylococci and anaerobes .
    Balhimycin
  • HY-109000A
    Afabicin disodium

    Debio 1450 disodium; AFN-1720 disodium

    		 Bacterial Infection
    Afabicin (Debio 1450) is the proagent of Debio1452, specifically targeting staphylococci without significant activity against other Gram-positive or Gram-negative species. Debio1452 is an inhibitor FabI, an enzyme critical to fatty acid biosynthesis in staphylococci .
    Afabicin disodium
  • HY-N14048
    Cepacin A

    		Antibiotic Bacterial Infection
    Cepacin A is an acetylenic antibiotic. Cepacin A has antibacterial activity, with a MIC of 0.2 μg/mL against staphylococci. In addition, Cepacin A is somewhat toxic to mice, with an LD50 of 30 mg/kg when administered intraperitoneally .
    Cepacin A
  • HY-B0925A
    Oxacillin

    		Bacterial Antibiotic Infection
    Oxacillin is an orally active synthetic penicillin with good bactericidal activity against staphylococci and other gram-positive pathogens .
    Oxacillin
  • HY-113602
    Paldimycin B

    Antibiotic 273 A1-beta

    		 Antibiotic Bacterial Infection
    Paldimycin B (Antibiotic 273 A1-beta) is a powerful semi-synthetic antibiotic with antibacterial activity against S. aureus and coagulase-negative staphylococci .
    Paldimycin B
  • HY-116039
    Epiroprim

    Ro11-8958

    		 Dihydrofolate reductase (DHFR) Bacterial Infection
    Epiroprim (Ro11-8958) is a selective dihydrofolate reductase (DHFR) inhibitor. Epiroprim displays excellent activity against staphylococci, enterococci, pneumococci, and streptococci .
    Epiroprim
  • HY-B0925R
    Oxacillin (sodium salt) (Standard)

    		Bacterial Antibiotic Infection
    Oxacillin (sodium salt) (Standard) is the analytical standard of Oxacillin (sodium salt). This product is intended for research and analytical applications. Oxacillin sodium salt is an orally active synthetic penicillin with good bactericidal activity against staphylococci and other gram-positive pathogens .
    Oxacillin (sodium salt) (Standard)
  • HY-B1252
    Cefalonium

    		Antibiotic Bacterial Infection Inflammation/Immunology
    Cefalonium is the first-generation β-lactam cephalosporin antibiotic that is widely used to research bovine mastitis caused by Gram-positive bacteria including staphylococci .
    Cefalonium
  • HY-B1252A
    Cefalonium hydrate

    		Antibiotic Bacterial Infection Inflammation/Immunology
    Cefalonium hydrate is the first-generation β-lactam cephalosporin antibiotic that is widely used to research bovine mastitis caused by Gram-positive bacteria including staphylococci .
    Cefalonium hydrate
  • HY-121474
    Dactimicin

    SF-2052

    		 Antibiotic Bacterial Infection
    Dactimicin is a pseudodisaccharide aminoglycoside. Dactimicin is an antibiotic that can inhibit the growth of methicillin-susceptible S. aureus isolates and coagulase-negative staphylococci with MIC50s of 2 μg/mL. Dactimicin is active against organisms possessing aminoglycoside-modifying enzymes .
    Dactimicin
  • HY-B1252R
    Cefalonium (Standard)

    		Antibiotic Bacterial Infection Inflammation/Immunology
    Cefalonium (Standard) is the analytical standard of Cefalonium. This product is intended for research and analytical applications. Cefalonium is the first-generation β-lactam cephalosporin antibiotic that is widely used to research bovine mastitis caused by Gram-positive bacteria including staphylococci .
    Cefalonium (Standard)
  • HY-B1252AS
    Cefalonium-d4 hydrate

    		Isotope-Labeled Compounds Infection
    Cefalonium-d4 (hydrate) is the deuterium labeled Cefalonium (hydrate)(HY-B1252A).Cefalonium hydrate is the first-generation β-lactam cephalosporin antibiotic that is widely used to research bovine mastitis caused by Gram-positive bacteria including staphylococci .
    Cefalonium-d4 hydrate
  • HY-B1050
    Gemifloxacin mesylate

    SB-265805S; LB-20304a

    		 Bacterial Antibiotic DNA/RNA Synthesis Topoisomerase Infection
    Gemifloxacin mesylate (SB-265805S; LB-20304a) is an orally active broad-spectrum quinolone antibacterial antibiotic. Gemifloxacin mesylate inhibits DNA synthesis by inhibiting DNA gyrase and Topoisomerase IV activities. Gemifloxacin mesylate has potent antibacterial activities against gram-positive bacteria in vitro efficacy study, particularly Streptococci and Staphylococci. Gemifloxacin mesylate has been used in the research of respiratory tract infections .
    Gemifloxacin mesylate
  • HY-146331
    PC190723

    		Bacterial Infection
    PC190723 is a bacterial cell division protein FtsZ inhibitor (IC50 = 55 nM). PC 190723 prevents cell division. PC190723 has potent and selective bactericidal activity against staphylococci, including methicillin- and multi-drug-resistant Staphylococcus aureus. PC190723 induces nucleated assembly of Bs-FtsZ into single-stranded coiled protofilaments and polymorphic condensates. PC190723 can be studied in anti-bacterial infection research .
    PC190723
  • HY-14956
    Nemonoxacin

    TG-873870

    		 Antibiotic Bacterial Infection Inflammation/Immunology
    Nemonoxacin (TG-873870) is an orally active and potent broad-spectrum antibiotic. Nemonoxacin shows good inhibitory activity against different species of staphylococci, streptococci, and enterococci, Neisseria gonorrhoeae, and Haemophilus influenza. Nemonoxacin can be used in the study of bacterial infections and community-acquired pneumonia .
    Nemonoxacin
  • HY-B1050R
    Gemifloxacin (mesylate) (Standard)

    		Bacterial Antibiotic DNA/RNA Synthesis Topoisomerase Infection
    Gemifloxacin (mesylate) (Standard) is the analytical standard of Gemifloxacin (mesylate). This product is intended for research and analytical applications. Gemifloxacin mesylate (SB-265805S; LB-20304a) is an orally active broad-spectrum quinolone antibacterial antibiotic. Gemifloxacin mesylate inhibits DNA synthesis by inhibiting DNA gyrase and Topoisomerase IV activities. Gemifloxacin mesylate has potent antibacterial activities against gram-positive bacteria in vitro efficacy study, particularly Streptococci and Staphylococci. Gemifloxacin mesylate has been used in the research of respiratory tract infections .
    Gemifloxacin (mesylate) (Standard)
  • HY-125919
    Vulpinic acid

    		Reactive Oxygen Species Bacterial Endogenous Metabolite Infection Inflammation/Immunology
    Vulpinic acid, a lichen metabolite, decreases H2O2-induced ROS production, oxidative stress and oxidative stress-related damages in human umbilical vein endothelial cells (HUVEC). Vulpinic acid is active against staphylococci, enterococci, and anaerobic bacteria.Vulpinic acid has the potential for atherosclerosis research .
    Vulpinic acid
  • HY-106574
    Ceftobiprole medocaril

    BAL5788

    		 Bacterial Infection Inflammation/Immunology
    Ceftobiprole medocaril (BAL5788) is the parenteral proagent of Ceftobiprole (HY-112579). Ceftobiprole is a parenteral pyrrolidinone cephalosporin. Ceftobiprole is a broad-spectrum cephalosporin with high levels of in vitro activity against methicillin- (MRSA) and vancomycin-resistant staphylococci (VRSA) and penicillin-resistant streptococci. Ceftobiprole also inhibits gram-positive and gram-negative pathogens .
    Ceftobiprole medocaril
  • HY-106574A
    Ceftobiprole medocaril sodium

    BAL5788 sodium

    		 Bacterial Infection Inflammation/Immunology
    Ceftobiprole medocaril (BAL5788) sodium is the parenteral proagent of Ceftobiprole (HY-112579). Ceftobiprole is a parenteral pyrrolidinone cephalosporin. Ceftobiprole is a broad-spectrum cephalosporin with high levels of in vitro activity against methicillin- (MRSA) and vancomycin-resistant staphylococci (VRSA) and penicillin-resistant streptococci. Ceftobiprole also inhibits gram-positive and gram-negative pathogens .
    Ceftobiprole medocaril sodium
  • HY-112579
    Ceftobiprole
    2 Publications Verification

    Ro 63-9141; BAL 9141

    		 Bacterial Antibiotic Infection Inflammation/Immunology
    Ceftobiprole (Ro 63-9141) is a broad-spectrum cephalosporin with high levels of in vitro activity against methicillin- (MRSA) and vancomycin-resistant staphylococci (VRSA) and penicillin-resistant streptococci with a MIC90 value of 2 μg/mL for MRSA. Ceftobiprole also inhibits gram-positive and gram-negative pathogens. Ceftobiprole can be used for the study of hospital-acquired pneumonia (excluding ventilator-associated pneumonia) and community-acquired pneumonia .
    Ceftobiprole
  • HY-109000
    Afabicin

    Debio 1450; AFN-1720

    		 Bacterial Infection
    Afabicin (Debio 1450) is the proagent of Debio1452, specifically targeting staphylococci without significant activity against other Gram-positive or Gram-negative species. Debio1452 is an inhibitor FabI, an enzyme critical to fatty acid biosynthesis in staphylococci.
    Afabicin
  • HY-B0465
    Oxacillin sodium monohydrate
    Maximum Cited Publications
    12 Publications Verification

    		 Bacterial Antibiotic Infection
    Oxacillin sodium monohydrate is an antibiotic similar to Flucloxacillin used in resistant staphylococci infections study .
    Oxacillin sodium monohydrate
  • HY-U00255
    BO3482

    		Bacterial Infection
    BO3482 has Antimicrobial activity and can inhibit the growth of methicillin-resistant Staphylococci (MRS) with an MIC90 of 6.25 mg/mL.
    BO3482
  • HY-B1148A
    Furaltadone

    Altafur

    		 Bacterial Infection
    Furaltadone, a nitrofuran agent, has the potential for the study in infections of chickens with salmonella enteritidis. Furaltadone is inhibitory and bactericidal in vitro for staphylococci .
    Furaltadone
  • HY-B1043
    Piromidic acid

    		Bacterial Antibiotic Infection
    Piromidic acid is an antibacterial agent. Piromidic acid is active against gramnegative bacteria and staphylococci and can be used for the research of intestinal, urinary, and biliary tract infections .
    Piromidic acid
  • HY-B0465R
    Oxacillin (sodium monohydrate) (Standard)

    		Bacterial Antibiotic Infection
    Oxacillin (sodium monohydrate) (Standard) is the analytical standard of Oxacillin (sodium monohydrate). This product is intended for research and analytical applications. Oxacillin sodium monohydrate is an antibiotic similar to Flucloxacillin used in resistant staphylococci infections study .
    Oxacillin (sodium monohydrate) (Standard)
  • HY-B0269
    Rifapentine
    1 Publications Verification

    DL 473; Cyclopentylrifampicin

    		 Antibiotic Bacterial Infection
    Rifapentine (DL 473) is an antibiotic used in tuberculosis research .
    Rifapentine
  • HY-B0269R
    Rifapentine (Standard)

    		Antibiotic Bacterial Infection
    Rifapentine (Standard) is the analytical standard of Rifapentine. This product is intended for research and analytical applications. Rifapentine (DL 473) is an antibiotic used in tuberculosis research .
    Rifapentine (Standard)
  • HY-N6665A
    Cefquinome

    		Antibiotic Bacterial Infection
    Cefquinome is a broad-spectrum cephem antibiotic that has inhibitory effects on a variety of Gram-positive and Gram-negative bacteria, including Staphylococci, Streptococci, Pseudomonas, and Enterobacteriaceae .
    Cefquinome
  • HY-131989
    Desacetylcephapirin sodium

    Deacetylcephapirin sodium

    		 Bacterial Infection
    Desacetylcephapirin (Deacetylcephapirin) sodium is an active metabolite of Cephapirin (HY-A0153A). Desacetylcephapirin sodium has antimicrobial against S. aureus and coagulase-negative staphylococci mastitis pathogen .
    Desacetylcephapirin sodium
  • HY-B1148B
    Furaltadone L-tartrate

    Altafur L-tartrate

    		 Bacterial Infection Inflammation/Immunology
    Furaltadone L-tartrate (Altafur L-tartrate), a nitrofuran agent, has the potential for the study in infections of chickens with salmonella enteritidis. Furaltadone is inhibitory and bactericidal in vitro for staphylococci .
    Furaltadone L-tartrate
  • HY-B0925AS
    Oxacillin-d5

    		Bacterial Antibiotic Infection
    Oxacillin-d5 is the deuterium labeled Oxacillin . Oxacillin is an orally active synthetic penicillin with good bactericidal activity against staphylococci and other gram-positive pathogens .
    Oxacillin-d5
  • HY-N6665
    Cefquinome sulfate

    		Antibiotic Bacterial Infection
    Cefquinome sulfate is a broad-spectrum cephem antibiotic that has inhibitory effects on a variety of Gram-positive and Gram-negative bacteria, including Staphylococci, Streptococci, Pseudomonas, and Enterobacteriaceae .
    Cefquinome sulfate
  • HY-B1148AR
    Furaltadone (Standard)

    		Bacterial Infection
    Furaltadone (Standard) is the analytical standard of Furaltadone. This product is intended for research and analytical applications. Furaltadone, a nitrofuran agent, has the potential for the study in infections of chickens with salmonella enteritidis. Furaltadone is inhibitory and bactericidal in vitro for staphylococci .
    Furaltadone (Standard)
  • HY-B1148R
    Furaltadone (hydrochloride) (Standard)

    		Bacterial Inflammation/Immunology
    Furaltadone (hydrochloride) (Standard) is the analytical standard of Furaltadone (hydrochloride). This product is intended for research and analytical applications. Furaltadone hydrochloride, a nitrofuran agent, has the potential for the study in infections of chickens with salmonella enteritidis. Furaltadone is inhibitory and bactericidal in vitro for staphylococci .
    Furaltadone (hydrochloride) (Standard)
  • HY-B1148AS
    Furaltadone-d5

    Altafur-d5

    		 Bacterial Isotope-Labeled Compounds Others
    Furaltadone-d5 is the deuterium labeled Furaltadone (HY-B1148A). Furaltadone, a nitrofuran agent, has the potential for the study in infections of chickens with salmonella enteritidis. Furaltadone is inhibitory and bactericidal in vitro for staphylococci .
    Furaltadone-d5
  • HY-B1043R
    Piromidic acid (Standard)

    		Bacterial Antibiotic Infection
    Piromidic acid (Standard) is the analytical standard of Piromidic acid. This product is intended for research and analytical applications. Piromidic acid is an antibacterial agent. Piromidic acid is active against gramnegative bacteria and staphylococci and can be used for the research of intestinal, urinary, and biliary tract infections .
    Piromidic acid (Standard)
  • HY-121182
    Chalcomycin

    		Antibiotic Bacterial Infection
    Chalcomycin is a macrolide antibiotic, which exhibits antimicrobial activities against gram-positive Staphylococcus aureus and Streptococcus pyogenes. Chalcomycin protects mice from infection with a variety of staphylococci and streptococc, without significant toxicity (LD50 >2500 mg/kg) .
    Chalcomycin
  • HY-N6665R
    Cefquinome sulfate (Standard)

    		Antibiotic Bacterial Infection
    Cefquinome (sulfate) (Standard) is the analytical standard of Cefquinome (sulfate). This product is intended for research and analytical applications. Cefquinome sulfate is a broad-spectrum cephem antibiotic that has inhibitory effects on a variety of Gram-positive and Gram-negative bacteria, including Staphylococci, Streptococci, Pseudomonas, and Enterobacteriaceae .
    Cefquinome sulfate (Standard)
  • HY-117845
    Citreamicin alpha

    LL-E19085α

    		 Bacterial Antibiotic Infection
    Citreamicin alpha (LL-E 19085-alpha) is an antibiotic whose in vitro antimicrobial activity against 429 clinical isolates of Gram-positive cocci has been tested by the agar dilution method. These microorganisms included 313 strains of Staphylococci and 116 strains of Streptococci. The in vitro activity of Citreamicin alpha was compared with that of ampicillin, amoxicillin, ceftriaxone, erythromycin, and vancomycin. For Staphylococci, the MIC values of Citreamicin alpha ranged from 0.12-4.0 μg/ml, and for Streptococcus pyogenes of the genus Streptococcus, it was 0.03-0.12 μg/ml. However, enterococci were relatively resistant, requiring 2.0 μg/ml of the agent to inhibit 64% of the 62 tested strains. The in vitro activity of this antibiotic was much better than that of ampicillin, amoxicillin, ceftriaxone, and erythromycin, but comparable or slightly inferior to that of vancomycin.
    Citreamicin alpha
  • HY-135184
    Rifaquizinone

    CBR-2092; TNP-2092

    		 Antibiotic Bacterial DNA/RNA Synthesis Infection
    Rifaquizinone (CBR-2092) is a Rifamycin-Quinolone Hybrid Antibiotic. Rifaquizinone inhibits wild-type S. aureus RNA polymerase with an IC50 of 34 nM. Rifaquizinone is effective against S. aureus infections, with MICs ranged from 0.008 to 0.5 μg/mL for 300 clinical isolates of staphylococci and streptococci .
    Rifaquizinone
  • HY-14956S1
    Nemonoxacin-d3-1

    TG-873870-d3-1

    		 Bacterial Inflammation/Immunology
    Nemonoxacin-d3-1 is the deuterium labeled Nemonoxacin. Nemonoxacin (TG-873870) is an orally active and potent broad-spectrum antibiotic. Nemonoxacin shows good inhibitory activity against different species of staphylococci, streptococci, and enterococci, Neisseria gonorrhoeae, and Haemophilus influenza. Nemonoxacin can be used in the study of bacterial infections and community-acquired pneumonia .
    Nemonoxacin-d3-1
  • HY-106668
    Isepamicin

    Sch 21420

    		 Antibiotic Bacterial Infection
    Isepamicin (Sch 21420) is an aminoglycoside antibacterial. Isepamicin has better activity against strains producing type I 6'-acetyltransferase. Isepamicin’s antibacterial spectrum includes Enterobacteriaceae and staphylococci. Anaerobes, Neisseriaceae and streptococci are resistant. Isepamicin exhibits a strong concentration-dependent bactericidal effect, a long post-antibiotic effect (several hours) and induces adaptive resistance .
    Isepamicin
  • HY-14956S
    Nemonoxacin-d3

    TG-873870-d3

    		 Bacterial Inflammation/Immunology
    Nemonoxacin-d3 is the deuterium labeled Nemonoxacin. Nemonoxacin (TG-873870) is an orally active and potent broad-spectrum antibiotic. Nemonoxacin shows good inhibitory activity against different species of staphylococci, streptococci, and enterococci, Neisseria gonorrhoeae, and Haemophilus influenza. Nemonoxacin can be used in the study of bacterial infections and community-acquired pneumonia .
    Nemonoxacin-d3
  • HY-N14699
    Diphenicillin

    Ancillin free acid; 2-Biphenylyl penicillin free acid; SKF-12141 free acid

    		 Penicillin-binding protein (PBP) Bacterial Infection
    Diphenicillin (Ancillin (free acid); 2-Biphenylyl penicillin (free acid); SKF-12141 (free acid)) is a Penicillinase (HY-E70012)- resistant penicillin with antibacterial activity. Diphenicillin shows good antibacterial effects against Gram-positive cocci. Diphenicillin is promising for research of infectious diseases caused by Gram-positive cocci such as staphylococci, pneumococci, and group A streptococci .
    Diphenicillin
  • HY-14956S2
    Nemonoxacin-d4

    TG-873870-d4

    		 Bacterial Inflammation/Immunology
    Nemonoxacin-d4 is the deuterium labeled Nemonoxacin. Nemonoxacin (TG-873870) is an orally active and potent broad-spectrum antibiotic. Nemonoxacin shows good inhibitory activity against different species of staphylococci, streptococci, and enterococci, Neisseria gonorrhoeae, and Haemophilus influenza. Nemonoxacin can be used in the study of bacterial infections and community-acquired pneumonia .
    Nemonoxacin-d4
  • HY-139805
    Ticarcillin

    		Antibiotic Bacterial Infection
    Ticarcillin is a semisynthetic, extended-spectrum, carboxypenicillin antibacterial agent, and is active against gram-positive cocci, including streptococci and staphylococci. Ticarcillin is also effective against most gram-negative organisms, including Pseudomonas aeruginosa. Ticarcillin can be used in lower respiratory tract infections, skin and skin structure infections, urinary tract infections, and intraabdominal infections research .
    Ticarcillin

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: